Allogene Therapeutics
Clinical trials sponsored by Allogene Therapeutics, explained in plain language.
-
Off-the-Shelf CAR t cells show promise for Hard-to-Treat myeloma
Disease control CompletedThis early-phase study tested a new type of CAR T cell therapy, called ALLO-715, in 73 adults with multiple myeloma that had returned or stopped responding to at least three prior treatments. Unlike standard CAR T cells made from a patient's own cells, ALLO-715 is made from a hea…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Off-the-Shelf CAR t cells show promise for tough lymphomas
Disease control CompletedThis early-phase study tested a new type of cancer treatment called ALLO-501, which is a 'off-the-shelf' CAR T cell therapy made from donor cells. It was given to 50 adults with large B-cell lymphoma or follicular lymphoma that had come back or stopped responding to at least two …
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 17, 2026 07:59 UTC